CLOs on the Move

Wright Medical

www.wright.com

 
Wright Medical Group N.V. is a global medical device company focused on providing extremity and biologic solutions that enable clinicians to alleviate pain and restore their patients` lifestyles. The company is a recognized leader of surgical solutions for the upper extremity (shoulder, elbow, wrist and hand), lower extremity (foot and ankle) and biologics markets, three of the fastest growing segments in orthopaedics.
  • Number of Employees: 1K-5K
  • Annual Revenue: $500M-1 Billion
  • www.wright.com
  • 1023 Cherry Road
    Memphis, TN USA 38117
  • Phone: 800.238.7117

Executives

Name Title Contact Details
Rick Franzen
Sr. Director- Intellectual Property and Chief Intellectual Property Counsel Profile
Kristine Tucker
Vice President, Global Regulatory Affairs Profile

Similar Companies

Heritage Living Ctr

Heritage Living Ctr is a Ashland, MT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tia

Founded in 2017 by Carolyn Witte and Felicity Yost, Tia is bringing the new standard of care for women for women in NY, LA, SF and PHX. Blending in-person and virtual care services, Tia`s “Whole Woman, Whole Life” care model fuses gynecology, primary care, mental health and evidence-based wellness services to treat women comprehensively. By bringing collaborative, comprehensive, and compassionate care, Tia is raising the bar for women and empowering them to achieve optimal health, on their terms.

Canadian Aboriginal AIDS Network

Canadian Aboriginal AIDS Network is a Vancouver, BC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

scPharmaceuticals

scPharmaceuticals, based in Lexington, MA, is a privately held biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery. Based on widely used generic drugs that currently require intravenous or intramuscular injections, our innovative products will be administered subcutaneously via a proprietary patch pump. This avoids material risks and costs associated with the current delivery options. Our lead products are the first subcutaneous formulations of furosemide (the most widely used parenteral diuretic in treating heart failure) and ceftriaxone (the most widely used parenteral antibiotic outside the hospital setting). Our novel furosemide formulation enables convenient anytime anywhere use, for example in an outpatient setting instead of the emergency room or other in-patient settings. For ceftriaxone and other antibiotics, subcutaneous administration eliminates the need for PICCs (peripherally inserted central catheters), which are associated with serious complications, frequent adverse events and high medical cost. For further information on how we are transforming the administration of parenteral drugs.

Cenegenics

Get a personalized medical team of experts that tests for and treats the earliest signs and avoidable symptoms associated with chronic disease and aging.